Lv4
470 积分 2021-01-25 加入
Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients
4小时前
已完结
LBA12 Efficacy of RLY-4008, a highly selective FGFR2 inhibitor in patients (pts) with an FGFR2-fusion or rearrangement (f/r), FGFR inhibitor (FGFRi)-naïve cholangiocarcinoma (CCA): ReFocus trial
18天前
已完结
Targeting fibroblast growth factor receptor (FGFR) with inhibitors in head and neck cancers: Their roles, mechanisms and challenges
22天前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
22天前
已完结
Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests
1个月前
已完结
Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinib
3个月前
已完结
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer
5个月前
已完结
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
5个月前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
5个月前
已完结
皖公网安备34019202002308
